A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers
Public ClinicalTrials.gov record NCT06453187. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Prospective, Randomized, Controlled Platform Trial Assessing Clinical Utility of Cellular, Acellular and Matrix-like Products (CAMPs) and Standard of Care vs SOC Alone in Hard-to-Heal Diabetic Foot and Venous Leg Ulcers.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine how well multiple CAMPs (Cellular, Acellular and Matrix-Like Products) and Standard of Care work when compared to Standard of Care alone in achieving complete closure of hard-to-heal diabetic foot and venous leg ulcers.
Study identification
- NCT ID
- NCT06453187
- Recruitment status
- Enrolling by invitation
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 350 participants
Conditions and interventions
Conditions
Interventions
- Urinary Bladder Matrix (UBM) sheet device for Venous Leg Ulcers Device
- Urinary Bladder Matrix (UBM) sheet device for Diabetic Foot Ulcers Device
- AmnioExcel Plus for Venous Leg Ulcers Device
- AmnioExcel Plus for Diabetic Foot Ulcers Device
- Standard of Care Procedure
Device · Procedure
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 17, 2024
- Primary completion
- Dec 30, 2026
- Completion
- Mar 30, 2027
- Last update posted
- Jul 26, 2026
2024 – 2027
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Angel City Research | Los Angeles | California | 90010 | — |
| Center for Clinical Research | San Francisco | California | 94115 | — |
| ILD Research Center | Vista | California | 92081 | — |
| Family Foot & Ankle Specialists, LLC | Bridgeport | Connecticut | 06606 | — |
| Denali Health Plant City, LLC | Plant City | Florida | 33564 | — |
| Barry University Clinical Research | Tamarac | Florida | 33321 | — |
| Denali Health | Atlanta | Georgia | 30083 | — |
| SitePath Research | Evergreen Park | Illinois | 60805 | — |
| Midwest Foot and Ankle Clinics | Hoffman Estates | Illinois | 60169 | — |
| Louisiana Foot & Ankle Specialists | Lake Charles | Louisiana | 70605 | — |
| MedStar Franklin Square Medical Center | Baltimore | Maryland | 21044 | — |
| MedStar Good Samaritan Hospital | Baltimore | Maryland | 21239 | — |
| Comprehensive Wound Healing Center, Northwell Health | Lake Success | New York | 11042 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06453187, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 26, 2026 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06453187 live on ClinicalTrials.gov.